CompuGroup Medical SE: Release of a capital market information

DGAP Post-admission Duties announcement: CompuGroup Medical SE / Share Buyback CompuGroup Medical SE: Release of a capital market information 10.09.2018 / 10:57 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 8th Interim Announcement CompuGroup Medical SE / Share Buyback Koblenz, September 10, 2018 CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 8th Interim Announcement In the period from September 03, 2018, up to and including September 07, 2018, CompuGroup Medical SE has bought back a total of 27,841 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of July 13, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on July 16, 2018. The overall volume of the shares bought back daily in the period from September 03, 2018, up to and including September 07, 2018, and the daily volume-weighted average stock market prices of the shares are as follows: Date Overall volume of Volume-weighted average shares bought back stock market price (number) (EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice) September 03, 2018 3,799 49.7335 September 04, 2018 7,404 49.4533 September 05, 2018 9,500 49.6262 September 06, 2018 4,296 48.9209 September 07, 2018 2,842 48.9418 In total: 27,841 49.4162 The total number of shares which have been bought back so far by CompuGroup Medical SE since July 16, 2018, up to and including September 07, 2018, within the framework of the share buyback program thus amounts to 286,465 no-par value shares. Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb. The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading). Koblenz, September 10, 2018 The Management Board CompuGroup Medical SE Investor Relations Maria Trost 21 56070 Koblenz, Germany T: 49 (0) 261 8000-6200 F: 49 (0) 261 8000-3200 10.09.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	CompuGroup Medical SE
	Maria Trost 21
	56070 Koblenz
	Germany
Internet:	www.cgm.com

End of News	DGAP News Service

721923  10.09.2018